Saturday 17 October 2026
Export GMED’s income statement to Excel — free account
Globus Medical, Inc.
GMED Healthcare Medical Devices
Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024. In the quarter to June 2026, revenue grew 5.94%, EPS fell 25.3% and free cash flow grew 571.3%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.
76.71
2.13
−2.70%
Follow GMED
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
21.94 | 110.28 | 45.05 | 38.71 | 48.78 | 62.71 | 37.27 | 27.05 | 38.54 | 22.95 |
Piotroski F-Score |
9 | 5 | 3 | 6 | 7 | 5 | 3 | 6 | 6 | 5 |
Altman Z-Score |
11.30 | 7.46 | 4.39 | 21.65 | 22.29 | 24.34 | 29.31 | 24.51 | 24.06 | 17.57 |
P/S ratio |
4.02 | 4.46 | 3.83 | 7.19 | 7.59 | 8.15 | 7.43 | 5.94 | 6.53 | 4.20 |
P/FCF ratio |
20.75 | 27.70 | 36.39 | 70.39 | 33.15 | 47.58 | 57.67 | 33.37 | 38.56 | 22.18 |
Altman Z″-Score (non-manufacturers) |
10.06 | 6.66 | 6.73 | 13.73 | 13.48 | 14.34 | 16.81 | 16.62 | 15.62 | 15.54 |
Beneish M-Score |
(2.31) | (2.59) | (1.83) | (2.22) | (2.61) | (2.84) | (2.38) | (2.26) | (2.47) | (2.40) |
P/Operating CF |
47.49 | 53.37 | 57.43 | 114.89 | 95.38 | 80.18 | 107.50 | 95.65 | 92.66 | 90.01 |
P/B ratio |
2.58 | 2.69 | 1.50 | 3.98 | 4.18 | 4.27 | 4.16 | 3.57 | 4.29 | 2.85 |
Price to Tangible BV |
4.93 | 5.76 | 3.67 | 4.64 | 4.87 | 5.09 | 4.89 | 4.35 | 5.43 | 3.57 |
EV/Sales |
4.12 | 4.44 | 3.78 | 6.76 | 7.13 | 7.61 | 7.04 | 5.47 | 5.95 | 3.69 |
EV/EBITDA |
15.47 | 16.93 | 16.53 | 22.91 | 27.94 | 34.35 | 24.72 | 18.33 | 18.26 | 10.38 |
EV/Operating CF |
16.07 | 21.51 | 24.33 | 38.71 | 24.74 | 30.22 | 32.15 | 21.45 | 23.77 | 14.07 |
EV/FCF |
21.28 | 27.63 | 35.86 | 66.17 | 31.15 | 44.46 | 54.62 | 30.70 | 35.09 | 19.46 |
Quick Ratio |
2.61 | 1.72 | 2.61 | 4.17 | 4.35 | 4.76 | 4.25 | 5.04 | 5.36 | 4.84 |
Current Ratio |
4.26 | 2.54 | 4.88 | 6.18 | 6.17 | 6.80 | 6.17 | 6.56 | 6.67 | 6.43 |
Net Debt/EBITDA |
(0.71) | (0.68) | (0.28) | (1.48) | (1.79) | (2.41) | (1.38) | (1.60) | (1.80) | (1.45) |
Debt/Assets |
0.00% | 8.44% | 8.21% | 0.00% | 0.26% | 0.30% | 0.13% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.11 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.56 | 0.49 | 0.44 | 0.51 | 0.53 | 0.49 | 0.55 | 0.60 | 0.63 | 0.64 |
Operating CF/Net income |
1.40 | 5.06 | 1.98 | 0.94 | 1.85 | 1.94 | 1.11 | 1.16 | 1.48 | 1.42 |
Capex/Depreciation |
(0.58) | (0.23) | (0.35) | (1.01) | (0.78) | (1.00) | (1.37) | (1.26) | (1.13) | (0.88) |
| 12.29% | 2.52% | 4.20% | 10.60% | 9.19% | 7.03% | 11.99% | 14.53% | 11.93% | 13.49% | |
| 10.19% | 1.99% | 3.43% | 9.43% | 8.20% | 6.37% | 10.96% | 13.15% | 10.70% | 11.85% | |
ROIC |
7.47% | 2.78% | 2.14% | 10.17% | 8.25% | 6.42% | 9.84% | 12.51% | 17.03% | 17.80% |
Return on Tangible Assets |
24.54% | 5.47% | 5.82% | 17.81% | 15.78% | 11.14% | 20.00% | 22.15% | 16.01% | 18.70% |
Average Days of Receivables |
92.36 | 83.79 | 117.49 | 77.55 | 63.11 | 68.51 | 75.49 | 73.90 | 71.97 | 61.99 |
Research and Development Expense of Revenue |
5.01% | 6.50% | 7.91% | 7.14% | 10.16% | 10.71% | 7.65% | 7.78% | 6.87% | 7.90% |
Selling, General and Administrative Expense of Revenue |
40.10% | 38.95% | 41.05% | 42.25% | 42.60% | 44.96% | 45.17% | 43.70% | 42.11% | 39.39% |
Intangible Assets out of Total Assets |
0.41 | 0.42 | 0.46 | 0.13 | 0.13 | 0.15 | 0.14 | 0.16 | 0.19 | 0.18 |
Share Based Compensation of Revenue |
1.69% | 2.15% | 3.36% | 3.21% | 3.19% | 3.43% | 3.32% | 3.07% | 2.31% | 2.02% |
Graham Net Nets |
0.12 | 0.10 | 0.14 | 0.10 | 0.09 | 0.10 | 0.10 | 0.12 | 0.12 | 0.18 |
Graham Number |
55.03 | 22.79 | 30.64 | 27.96 | 23.99 | 18.91 | 22.42 | 20.88 | 15.92 | 14.54 |
Earnings Yield |
4.56% | 0.91% | 2.22% | 2.58% | 2.05% | 1.59% | 2.68% | 3.70% | 2.59% | 4.36% |
Free Cash Flow Yield |
4.82% | 3.61% | 2.75% | 1.42% | 3.02% | 2.10% | 1.73% | 3.00% | 2.59% | 4.51% |
Revenue per Share |
21.74 | 18.56 | 13.87 | 10.18 | 9.51 | 8.00 | 7.92 | 7.28 | 6.61 | 5.90 |
Operating CF per Share |
5.57 | 3.84 | 2.15 | 1.78 | 2.74 | 2.02 | 1.73 | 1.86 | 1.65 | 1.55 |
Capex per Share |
(1.29) | (0.85) | (0.69) | (0.74) | (0.56) | (0.65) | (0.71) | (0.56) | (0.53) | (0.43) |
Free Cash Flow per Share |
4.28 | 2.99 | 1.46 | 1.04 | 2.18 | 1.37 | 1.02 | 1.30 | 1.12 | 1.12 |
Cash per Share |
4.12 | 6.56 | 4.58 | 4.44 | 4.40 | 4.33 | 3.14 | 3.47 | 3.88 | 3.04 |
Shareholders Equity per Share |
33.82 | 30.78 | 35.35 | 18.38 | 17.29 | 15.28 | 14.14 | 12.11 | 10.06 | 8.70 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
33.82 | 30.78 | 35.35 | 18.38 | 17.29 | 15.28 | 14.14 | 12.11 | 10.06 | 8.70 |
Free Cash Flow |
579.02 | 405.21 | 165.23 | 104.42 | 219.38 | 135.14 | 101.23 | 126.95 | 107.76 | 106.91 |
Working Capital |
1,627.11 | 1,321.35 | 1,523.03 | 824.14 | 724.35 | 700.97 | 576.07 | 534.56 | 527.27 | 433.87 |
Capital Expenditures |
(174.42) | (115.43) | (78.27) | (74.05) | (56.90) | (63.66) | (70.75) | (54.70) | (51.30) | (40.91) |
Net Current Asset Value |
1,396.10 | 1,102.84 | 827.25 | 753.59 | 648.64 | 648.58 | 557.84 | 515.53 | 509.62 | 418.21 |
EV/EBIT |
25.24 | 67.45 | 44.50 | 30.31 | 39.75 | 53.91 | 32.14 | 23.01 | 23.36 | 13.50 |
Capex to Sales |
0.06 | 0.05 | 0.05 | 0.07 | 0.06 | 0.08 | 0.09 | 0.08 | 0.08 | 0.07 |
Price to Operating Income |
24.60 | 67.63 | 45.15 | 32.25 | 42.30 | 57.70 | 33.94 | 25.02 | 25.67 | 15.38 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.54 | 0.88 | 0.38 | 0.30 | 0.33 | 0.29 | 0.26 | 0.25 | 0.32 | 0.37 |
Cash ROIC |
11.29% | 7.35% | 3.35% | 4.56% | 10.02% | 6.97% | 5.90% | 8.32% | 8.03% | 9.52% |
Accounts Receivable Turnover |
4.45 | 4.65 | 4.34 | 5.34 | 6.11 | 5.08 | 5.12 | 5.29 | 5.75 | 6.19 |
Accounts Payable Turnover |
11.01 | 15.71 | 11.82 | 9.09 | 11.91 | 10.16 | 7.13 | 6.26 | 7.08 | 8.06 |
Inventory Turnover |
1.35 | 1.37 | 0.96 | 0.98 | 1.03 | 1.02 | 1.10 | 1.33 | 1.36 | 1.24 |
Average Days of Payables |
37.67 | 26.48 | 37.73 | 49.96 | 33.50 | 30.56 | 49.92 | 59.29 | 60.74 | 47.34 |
Days of Inventory on Hand |
289.35 | 232.38 | 564.73 | 413.79 | 361.61 | 384.62 | 398.14 | 300.53 | 263.00 | 305.35 |
Average Receivables |
661.00 | 541.60 | 361.09 | 191.48 | 156.88 | 155.26 | 153.39 | 134.87 | 110.59 | 91.07 |
Average Payables |
86.99 | 65.89 | 46.39 | 29.03 | 20.08 | 21.41 | 25.25 | 25.47 | 21.26 | 16.72 |
Average Inventory |
709.26 | 753.68 | 573.56 | 267.99 | 233.08 | 212.73 | 163.78 | 119.83 | 110.55 | 108.98 |
Average Assets |
5,277.26 | 5,168.92 | 3,581.10 | 2,016.69 | 1,818.37 | 1,605.78 | 1,416.37 | 1,189.59 | 1,003.07 | 880.87 |
Average Common Equity |
4,375.29 | 4,087.65 | 2,922.17 | 1,793.88 | 1,623.84 | 1,454.37 | 1,293.98 | 1,076.65 | 899.93 | 773.70 |
Columns are period end dates